Andy Chevigné and his team, RTI-5152-12 is postulated to improve the levels of opioid peptides that bind to classical opioid receptors inside the Mind, leading to heightened painkilling action. The LIH-RTI study teams recognized a collaboration agreement and filed a joint patent applicati